Drug firm Dr.Reddy’s Laboratories, on Friday, said it had launched its generic Decitabine injection used in treatment of cancer in the American market after receiving approval from the U.S. health regulator. The company has launched the Decitabine for injection in the strength of 50 mg in the U.S. market following approval by the United States Food & Drug Administration (USFDA) of Dr Reddy’s abbreviated new drug applications (ANDA), it said in a statement.

More In: Industry | Business